cardiovascular disease

(redirected from Cardiovascular diseases)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to cardiovascular disease

References in periodicals archive ?
ISLAMABAD -- People with severe mental illness are at a substantially increased risk for developing cardiovascular disease compared to the general population, according to a recent study.
Maternal undernutrition can lead to intrauterine growth retardation and has been shown to increase the risk of metabolic disorders such as diabetes, hypertension, and cardiovascular disease in the offspring.
It is a terrible indictment of the entire medical establishment that we experience such high rates of cardiovascular diseases, suffer such misery, and spend so much money on a medical approach to a largely avoidable disease.
Possible benefits include reduced risk of cardiovascular disease and cancer, maintenance of healthy skin.
Cardiovascular disease ranks as the leading cause of death in this country.
Cardiovascular disease (CVD) is the leading cause of death among Americans.
Therefore, in the present study we investigated the mechanism of arsenic-induced vascular dysfunction and its possible contribution to cardiovascular diseases.
The current study demonstrates that EP-3533 can distinguish viable from non-viable myocardium, a potential large market opportunity in cardiovascular disease imaging.
However, the diversity of cardiovascular diseases arising from chronic arsenic exposure also raises the possibility that arsenic may alter the normal functioning of blood vessels, which are involved in various cardiovascular disorders.
Amorcyte), a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, announced today that its phase I clinical trial is now open in two new clinical sites and the data safety monitoring board has approved the trial going forward to the second stage using, as per the approved protocol, an increased number of stem cells.
Servier is entering into this collaboration with Plexxikon as a key step in our strategy to expand our efforts in the development of new drugs for cardiovascular diseases.
The general principle is that once blood perfusion is increased in the affected areas, patients with cardiovascular diseases may experience an improvement in tissue repair and function.
When blood perfusion is established in affected areas, patients with cardiovascular diseases may experience an increase in life expectancy and quality of life.
OTCBB:CVBT) today announced that it has engaged The Bruckner Group (BGI) to help develop the value proposition for its drug candidates for the treatment of cardiovascular diseases formulated with Cardio Vascu-Grow(TM).
Once blood perfusion is established in the affected areas, patients with cardiovascular diseases may experience a better quality of life.
Full browser ?